Jpmorgan Chase & CO Valneva Se Transaction History
Jpmorgan Chase & CO
- $1.51 Trillion
- Q3 2025
A detailed history of Jpmorgan Chase & CO transactions in Valneva Se stock. As of the latest transaction made, Jpmorgan Chase & CO holds 10,179 shares of VALN stock, worth $92,119. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,179
Previous 10,179
-0.0%
Holding current value
$92,119
Previous $124,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding VALN
# of Institutions
20Shares Held
5.27MCall Options Held
0Put Options Held
0-
Novo Holdings Hellerup, G72.35MShares$21.2 Million2.32% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA2.29MShares$20.7 Million1.18% of portfolio
-
General American Investors CO Inc354KShares$3.21 Million0.26% of portfolio
-
Wells Fargo & Company San Francisco, CA154KShares$1.39 Million0.0% of portfolio
-
Morgan Stanley New York, NY33KShares$298,5320.0% of portfolio
About Valneva SE
- Ticker VALN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,103,504
- Market Cap $625M
- Description
- Valneva SE, a specialty vaccine company, focuses on the development and commercialization of prophylactic vaccines for infectious diseases with unmet needs. Its commercial vaccines for travelers include IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; ...